Global Preventive Vaccines Market Trends and Competitive Analysis Report 2021 - 2028


Posted April 28, 2022 by MarketResearch7

The global preventive vaccines market size is estimated to expand at a substantial CAGR during the forecast period, 2021–2028.
 
The global preventive vaccines market size is estimated to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing healthcare expenditure, new development of the vaccines, and rising demand for preventive vaccines in low- and middle-income countries.

Vaccine supports the body’s immune system against future infections or disease. These vaccines consist of attenuated or killed microbes, or microbial DNA. The immune system produces antibodies after administration. It is agent-specific, relatively harmless, and antigenic components that can induce protective immunity against the corresponding infectious agent.

Routine immunization programs protect the children from a number of infectious diseases that previously caused millions of deaths each year. Effective immunization has eradicated number of diseases, such as polio and smallpox. Preventive vaccinations are essentially administered to people of different age groups, which strengthen their immune system throughout lifetime. Preventive vaccination provides the possibility of avoiding some infectious diseases.

Market Trends, Drivers, Restraints, and Opportunities
• Preventive vaccinations play a crucial role to maintain sustainable health of people. Thus, the growing awareness about benefits is estimated to propel the market expansion in the coming years.
• Increased funding from government and international organizations, and increasing awareness about preventive care are projected to drive the market expansion during the forecast period.
• Growing government support for vaccine development and rising focus on immunization are anticipated to boost the market growth during the forecast period.
• Huge capital investments required for developing vaccines can restrict the market growth.
• Preventive vaccines are not developed for several life-threatening conditions, restricting the market growth during the forecast period.
• Increasing R&D investment to enhance preventive vaccine is anticipated to create opportunities for the market expansion.
• The COVID-19 pandemic has increased the burden on the healthcare sector, spurring the market growth.

Preventive Vaccines Market Segment Insights

Live/attenuated vaccines segment to hold a major market share
Based on vaccine types, the market is segmented into live/attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, and others. The live/attenuated vaccines segment is expected to constitute a key market share during the forecast period. This type of vaccine is a weakened version does not cause any symptoms of infection.

Hepatitis segment to expand at a substantial CAGR
In terms of disease types, the market is divided into pneumococcal, poliovirus, hepatitis, influenza, measles, mumps & rubella (MMR), and others. The hepatitis segment is anticipated to register an impressive CAGR during the forecast period. Increasing incidence of the disease & infections and the presence of preventive vaccines are expected to fuel the market growth.

North America to dominate the market
On the basis of regions, the market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to the US as it is the largest contributor to its revenue. The Centers for Disease Control and Prevention's (CDC) and Advisory Committee for Immunization Practices (ACIP) publishes recommendations for adult and childhood vaccination. As per the World Health Organization (WHO) guidelines, the US has one of the leading healthcare systems and the vaccination coverage is estimated to drive the market growth.

Compititive Landscape
Key players competing in the preventive vaccines market include AstraZeneca PLC, Emergent BioSolutions Inc, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

About Growth Market Reports:
GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.

Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: [email protected]
Web: https://growthmarketreports.com
Follow Us: LinkedIn | Twitter
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Growth Market Reports
Country United States
Categories Health , Medical , Reports
Tags north america , preventive vaccines market , preventive vaccines market cagr , preventive vaccines market share , preventive vaccines market size , south america , uae , usa
Last Updated April 28, 2022